Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00101179. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT04188405. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00101595. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment
ClinicalTrials.gov study NCT03573596. IPD Sharing: UNDECIDED. Countries: 7. Publications: 1.
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00079378. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
ClinicalTrials.gov study NCT03678454. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00003145. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generati
ClinicalTrials.gov study NCT02885766. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00258271. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00257647. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00852566. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Mye
ClinicalTrials.gov study NCT04140487. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study
ClinicalTrials.gov study NCT01860456. IPD Sharing: Not stated. Countries: 1. Publications: 7.
International Chronic Myeloid Leukemia Pediatric Study
ClinicalTrials.gov study NCT01281735. IPD Sharing: Not stated. Countries: 20. Publications: 4.
Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
ClinicalTrials.gov study NCT00327262. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Glivec in Pediatric Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT00845221. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02627677. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05282108. IPD Sharing: NO. Countries: 1. Publications: 14.
Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02883036. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
ClinicalTrials.gov study NCT01702064. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.